When should a liver biopsy be performed on patients receiving MTX

When should a liver biopsy be performed on patients receiving MTX?

Routine baseline or periodic liver biopsies in patients receiving MTX are not recommended. Usually when liver tests are persistently or significantly elevated in patients on MTX, the dose is reduced and reevaluation is performed. If the liver function tests continue to be significantly elevated, MTX is usually stopped and therapy is switched. With the multitude of non-bDMARD and bDMARD therapies available, the underlying inflammatory disorder can usually be controlled with another nonhepatotoxic medication.

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856
Scroll to Top